TP53 and breast neoplasm: Further, since previous studies have indicated that concomitant ATM and p53 inactivation is underrepresented in breast tumors [22], we assessed the ATM levels among TP53 mutated versus wild-type tumors; no difference between the two groups was observed (P > 0.4).